Genetic Technologies’ $2 Million Direct Offering and Private Placement

Sichenzia Ross Ference Carmel represented Genetic Technologies Limited in the deal. Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company” or “Genetic Technologies”) announced the closing of its registered offering for the purchase...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here